Načítá se...
Effect of Tyrosin Kinase Inhibitors on NK Cell and ILC3 Development and Function
Tyrosin kinase inhibitors (TKI) sharply improved the prognosis of Chronic Myeloid Leukemia (CML) and of Philadelphia(+) Acute Lymphoblastic Leukemia (Ph(+)ALL) patients. However, TKI are not curative because of the development of resistance and lack of complete molecular remission in the majority of...
Uloženo v:
| Vydáno v: | Front Immunol |
|---|---|
| Hlavní autoři: | , , , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
Frontiers Media S.A.
2018
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6207002/ https://ncbi.nlm.nih.gov/pubmed/30405627 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fimmu.2018.02433 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|